Ridnõi Konstantin, Kurvinen Elvira, Pajusalu Sander, Reimand Tiia, Õunap Katrin
Center for Perinatal Care, Women's Clinic, East-Tallinn Central Hospital, Tallinn.
Department of Clinical Genetics, Institute of Clinical Medicine.
Mol Syndromol. 2018 Jul;9(4):205-213. doi: 10.1159/000490083. Epub 2018 Jun 8.
Fetal overgrowth and numerous congenital malformations can be detected in every trimester of pregnancy. New technologies in molecular testing, such as chromosomal microarray analysis and next-generation sequencing, continually demonstrate advantages for definitive diagnosis in fetal life. Simpson-Golabi-Behmel (SGB) syndrome is a rare but well-known overgrowth condition that is rarely diagnosed in the prenatal setting. We report 3 cases of SGB syndrome in 2 consecutive pregnancies. In our series, distinctive prenatal sonographic findings led to molecular diagnosis. Exome sequencing from fetal DNA revealed a hemizygous splice site variant in the gene: NM_004484.3:c.1166+ 1G>T. The mother is a heterozygous carrier. We also provide an overview of the previously published 57 prenatal cases of SGB syndrome with prevalence estimation of the symptoms to aid prenatal differential diagnosis of fetal overgrowth syndromes.
在孕期的每个阶段都能检测到胎儿过度生长和众多先天性畸形。分子检测中的新技术,如染色体微阵列分析和新一代测序,不断显示出在胎儿期进行明确诊断的优势。辛普森 - 戈拉比 - 贝梅尔(SGB)综合征是一种罕见但广为人知的过度生长疾病,在产前很少被诊断出来。我们报告了连续两例妊娠中的3例SGB综合征病例。在我们的系列病例中,独特的产前超声检查结果导致了分子诊断。对胎儿DNA进行外显子组测序发现基因NM_004484.3:c.1166 + 1G>T中有一个半合子剪接位点变异。母亲是杂合子携带者。我们还概述了先前发表的57例SGB综合征产前病例,并对症状的患病率进行了估计,以帮助对胎儿过度生长综合征进行产前鉴别诊断。